FDA Decision Opens Way to Generics of Original Opana ER FDA Decision Opens Way to Generics of Original Opana ER

Following a decision to block new generic versions of non-abuse-deterrent oxycodone, the FDA today denied a petition from Endo Pharmaceuticals, opening the way for new generic versions of oxymorphone. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news